HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 67.0% in 2014. ▲ Rising
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Eastern Mediterranean (WHO region), 2003–2014
Source: World Health Organization, Global Health Observatory.
Analysis
Eastern Mediterranean (WHO region) recorded 67.0% for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in 2014.
Compared with earlier readings it is up 11.7% on the previous year and up 204.5% over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Eastern Mediterranean (WHO region) peaked at 73.0% in 2012 and was at its lowest, 18.0%, in 2005.
The long-run direction has been consistently rising across the 12 years of available data.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 25.0% | — |
| 2004 | 22.0% | -12.0% |
| 2005 | 18.0% | -18.2% |
| 2006 | 21.0% | +16.7% |
| 2007 | 40.0% | +90.5% |
| 2008 | 42.0% | +5.0% |
| 2009 | 41.0% | -2.4% |
| 2010 | 50.0% | +22.0% |
| 2011 | 48.0% | -4.0% |
| 2012 | 73.0% | +52.1% |
| 2013 | 60.0% | -17.8% |
| 2014 | 67.0% | +11.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 29.9% | 18.0% | 42.0% | 7 |
| 2010s | 59.6% | 48.0% | 73.0% | 5 |
More health data for Eastern Mediterranean (WHO region)
- Pertussis - number of reported cases, gaps filled 14,992 (2025)
- Total tetanus - number of reported cases, gaps filled 524 (2025)
- Diphtheria - number of reported cases, gaps filled 5,830 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 482 (2025)
- Measles - number of reported cases, gaps filled 83,590 (2025)
- Number of under-five deaths, annual growth rate -2.69 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -2.01 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.36 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 6.13 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 140.84 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Eastern Mediterranean (WHO region)?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Eastern Mediterranean (WHO region) was 67.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 73.0% in 2012.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 18.0% in 2005.
- How does Eastern Mediterranean (WHO region) rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Eastern Mediterranean (WHO region) ranks 7th out of 11 groups with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 204.5%. The long-run trend across the full record is rising.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).